Annual Shareholders’ Meeting

Keywords: investor relations, Shareholders' Meeting
Division: Simulations Plus

Products and services span the entire drug development process from discovery to approval

Software Product Portfolio

  • Physiologically-based pharmacokinetic (PBPK) modeling platform
  • Predicts 140+ properties of chemical formulations
  • Quantitative Systems Toxicology (QST) and Quantitative Systems Pharmacology (QSP) for analyzing certain biological or disease states
  • Cloud-based web application to organize, process, maintain & communicate data and results over the duration of a drug development program
    8 Nasdaq: SLPConsulting Services
  • Support clients through entire drug development
    process from sketching chemicals to regulatory filings
  • Provide multi-disciplinary modeling and simulationsupport:
    ‒PBPK modeling
    ‒Population/PK analysis
    ‒Pharmacodynamic modeling
    ‒NONMEM analysis
    ‒Quantitative systems pharmacology and toxicology
    ‒Quantitative structure-activity relationship modeling
    ‒Data assembly and preparation of reports